Search

Showing "11155" results for ""

CROI: CCR5 antagonist SCH532706 shows potent activity and good tolerability in small trial

CROI: Risk of treatment interruption persists after restarting HAART

CROI: Vicriviroc appears safe and effective at higher doses in treatment-experienced patients after 48 weeks

CROI: Lactobacillus supplementation could help reduce vaginal HIV

CROI: Recurrent hepatitis C in HIV-positive gay men: relapse or reinfection?

CROI: DAD cohort finds increased risk of heart attack in people taking abacavir or ddI

CROI: Unplanned pregnancy frequent among women after starting ARVs, need for family planning

CROI: HAART use in mothers substantially reduces HIV infections in breastfeeding infants in Kisumu, Kenya

CROI: Extended infant nevirapine prophylaxis reduces HIV transmission through breastfeeding

CROI: AIDS vaccine: additional infection risk restricted to uncircumcised men

CROI: People receiving TB treatment no more likely to die than others who start ARVs

CROI: TDM-based PI dose escalation shows modest benefit in black and Hispanic, but not Caucasian, treatment-experienced patients

CROI: Darunavir found effective and tolerable in treatment-experienced children and adolescents at 24 weeks

CROI: Could earlier ART reduce risk of death from non-AIDS related illnesses in people with HIV?

CROI: Sustained response to hepatitis C treatment lowers liver complications and death in HIV/HCV coinfected people

CROI: Untreated HIV-positive individuals have a higher risk of death even at CD4 counts over 350

CROI: Delaying HAART while treating opportunistic infections increases the risk of disease progression and death

CROI: Biomarker changes may help explain detrimental effects of treatment interruption

Receive the latest HIV research and conference news

Showing "11155" results for ""

CROI: CCR5 antagonist SCH532706 shows potent activity and good tolerability in small trial

CROI: Risk of treatment interruption persists after restarting HAART

CROI: Vicriviroc appears safe and effective at higher doses in treatment-experienced patients after 48 weeks

CROI: Lactobacillus supplementation could help reduce vaginal HIV

CROI: Recurrent hepatitis C in HIV-positive gay men: relapse or reinfection?

CROI: DAD cohort finds increased risk of heart attack in people taking abacavir or ddI

CROI: Unplanned pregnancy frequent among women after starting ARVs, need for family planning

CROI: HAART use in mothers substantially reduces HIV infections in breastfeeding infants in Kisumu, Kenya

CROI: Extended infant nevirapine prophylaxis reduces HIV transmission through breastfeeding

CROI: AIDS vaccine: additional infection risk restricted to uncircumcised men

CROI: People receiving TB treatment no more likely to die than others who start ARVs

CROI: TDM-based PI dose escalation shows modest benefit in black and Hispanic, but not Caucasian, treatment-experienced patients

CROI: Darunavir found effective and tolerable in treatment-experienced children and adolescents at 24 weeks

CROI: Could earlier ART reduce risk of death from non-AIDS related illnesses in people with HIV?

CROI: Sustained response to hepatitis C treatment lowers liver complications and death in HIV/HCV coinfected people

CROI: Untreated HIV-positive individuals have a higher risk of death even at CD4 counts over 350

CROI: Delaying HAART while treating opportunistic infections increases the risk of disease progression and death

CROI: Biomarker changes may help explain detrimental effects of treatment interruption

Receive the latest HIV research and conference news